Guth MAS. Implementing 212 Pb-Targeted Alpha Therapy: A Safety-First Theranostic Framework for Clinical Practice. Clin Nucl Med Open. 2026;3(3):DOI: 10.1097/nm9.0000000000000092. Table 1. Target-Specific Organs at Risk and Mitigation Strategies for Pb-212-TAT and FAP-Targeted Analogs Organ/Tissue SSTR2/FAP Expression Primary Radiation Risk Proactive Mitigation and Monitoring Strategy Pituitary Gland High (SUVmax ≈ 15–25) Hypopituitarism (central hypothyroidism, hypogonadism, […]